SP‐D gene deficiency induces hyper‐eosinophilia, increased levels of IL‐5 and IL‐13, and a lowered IFN‐gamma to IL‐4 ratio, an immune response that is reversible by treatment with SP‐D.45, 46. Here, IL5 is linked to Increased total eosinophil count.